MUTYH-associated polyposis

Best Pract Res Clin Gastroenterol. 2009;23(2):209-18. doi: 10.1016/j.bpg.2009.03.006.

Abstract

MUTYH-associated polyposis (MAP) is an autosomal recessive disorder characterised by adenomatous polyps of the colorectum and a very high risk of colorectal cancer. It appears to be at least as prevalent as autosomal dominant familial adenomatous polyposis (that is caused by truncating mutations in the APC gene) with which it shares important gastroenterological features. It was first recognised as recently as 2002 and its full phenotype and natural history are still being characterised. Key extracolonic manifestations include a predisposition to duodenal adenomas and cancer and a modest increase in risk for several extraintestinal tumours. Testing for mutations in the MUTYH gene is indicated in patients who have multiple colorectal adenomas or a family history suggestive of autosomal recessive colorectal cancer and for the siblings and spouses of patients with MAP in order to inform surveillance and treatment for patients and their families.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenomatous Polyposis Coli / diagnosis
  • Adenomatous Polyposis Coli / genetics*
  • Adenomatous Polyposis Coli / therapy
  • Adult
  • Aged
  • DNA Glycosylases / genetics*
  • DNA Mutational Analysis
  • Early Detection of Cancer
  • Gene Expression Regulation, Neoplastic*
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Humans
  • Middle Aged
  • Patient Selection
  • Pedigree
  • Phenotype
  • Predictive Value of Tests
  • Risk Assessment
  • Young Adult

Substances

  • DNA Glycosylases
  • mutY adenine glycosylase